Brind.

Leadership appointments support continued growth for Foundation Medicine and Hoffmann-La Roche.

1 report, 1 independent Updated Jul 20

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Foundation Medicine Hoffmann-La Roche

Keep exploring

The entities involved

Foundation Medicine
American genomics company

Nothing else this week.
Hoffmann-La Roche
Swiss healthcare company
- Natera's Signatera test is undergoing a Phase III trial across US sites, sponsored by NRG Oncology, while facing patent litigation.Sun 02:44
- Hoffmann-La Roche opened a new R&D center in Boston.Sat 11:08

Coverage

Newest first; wire copies grouped

Jul 20yahoo.com